Print Page   |   Contact Us   |   Sign In   |   Join
News and Press
Filter news by category:

Read about the latest MichBio, member organization, and industry news.

 

Members: Click here to post your news!

Displaying page 7 of 10
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10

Member Organization News
Thursday, March 24, 2016   (0 Comments - view/add)
Ann Arbor-based RetroSense Begins Human Trials for Blindness Cure »
RetroSense Therapeutics, an Ann Arbor-based biomedical startup has begun human trials for a drug it's designed that could...
Friday, March 11, 2016   (0 Comments - view/add)
Stryker Closes $3.5B Notes Offering »
Stryker   (NYSE:SYK) said today that it closed a senior notes offering worth $3.5 billion....
Thursday, March 3, 2016   (0 Comments - view/add)
Empirical Bioscience Leaves Incubator for New Facility »
GRAND RAPIDS, MI - Empirical Bioscience , a company that produces high-grade PCR reagents and enzymes, announced to...
Monday, February 22, 2016   (0 Comments - view/add)
FDA Accepts Sanofi New Drug Application for Once-Daily Fixed Ratio Combination »
PARIS -  Sanofi   announced today that the U.S. Food and Drug Administration (FDA) has accepted the New...
Monday, February 22, 2016   (0 Comments - view/add)
Armune Bioscience of Kalamazoo Secures $9.1 Million in Series A Financing »
KALAMAZOO —   Armune Bioscience Inc .   raised nearly $9.1 million in a capital round to support further co...
Tuesday, February 16, 2016   (0 Comments - view/add)
Stryker to Make a $1.28 Billion Acquisition »
Medical device maker Stryker announced on Tuesday that it plans to buy Physio-Control International for $1.28 billion to...
Monday, February 15, 2016   (0 Comments - view/add)
Stryker to Acquire Neuro Portfolio From Synergetics »
KALAMAZOO — Medical device maker   Stryker Corp .   of Kalamazoo says it has signed a definitive agree...
Friday, February 12, 2016   (0 Comments - view/add)
ONL Therapeutics Receives Orphan Drug Designation for ONL1204 for Treatment of Retinal Detachment »
ANN ARBOR, MI – ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in...
Friday, February 5, 2016   (0 Comments - view/add)
UM Researcher Max Wicha Gets $6.5 million Grant for Cancer Stem Cell Research »
National Cancer Institute award will fund work for 7 years Max Wicha, M.D, the founder and director emeritus of the Un...
Friday, February 5, 2016   (0 Comments - view/add)
Empirical Bioscience Leaves Incubator for New Facility »
GRAND RAPIDS, MICH — Empirical Bioscience, a company that produces high-grade PCR reagents and enzymes, announced today th...
Friday, February 5, 2016   (0 Comments - view/add)
MPI Research Announces $5 Million Upgrade, 130 New Jobs; CEO to Retire »
MATTAWAN, MI   -- Drug and compound testing company MPI Research plans to spend $5 million to upgrade facilities a...
Friday, February 5, 2016   (0 Comments - view/add)
NSF to Acquire Food Safety Competitor Euro Consultants Group »
Ann Arbor-based   NSF International , global food safety auditing, training and consulting company, said it is in th...
Tuesday, February 2, 2016   (0 Comments - view/add)
Kalamazoo's Stryker Corp. to buy Sage Products for $2.8 billion »
Illinois company makes products to prevent hospital-acquired illnesses TOM HENDERSON Crain's Detroit Business...
Wednesday, January 20, 2016   (0 Comments - view/add)
Armune BioScience Expands Access to Apifiny with Accu Reference Medical Lab »
Kalamazoo, MI (PRWEB) January 19, 2016 Armune BioScience signed a definitive agreement with Accu Reference Medical La...
Tuesday, January 19, 2016   (0 Comments - view/add)
Michigan State Researcher Gets $4.2 million to Improve Bone Healing »
EAST LANSING — A   Michigan State University   researcher has been awarded $4.2 million in grants to help in h...
Wednesday, January 13, 2016   (0 Comments - view/add)
Esperion (ESPR) Announces Initiation Of Phase 3 Clinical Program With Long-Term Safety And Tolerabil »
— Company to Provide Details of Phase 3 Global Development Strategy in Q2 2016 — ANN ARBOR, Mich., Jan. 13, 2016 (...
Tuesday, January 12, 2016   (0 Comments - view/add)
Ann Arbor-based NSF Acquires Provider of DNA Testing for Raw Materials in Products »
Ann Arbor-based   NSF International   has acquired   AuthenTechnologies , a provider of next-generation,...
Thursday, January 7, 2016   (0 Comments - view/add)
Sex Pheromone Added to Lamprey Control Arsenal »
ANN ARBOR, MI — The U.S. Environmental Protection Agency has registered the first vertebrate pheromone biopesticide for us...
Tuesday, January 5, 2016   (0 Comments - view/add)
Millendo Therapeutics Sets Michigan Record by Raising $62 Million »
Ann Arbor-based Company Also Announces Partnership with Drug Giant AstraZeneca Ann Arbor-based   Millendo Thera...
Monday, December 21, 2015   (0 Comments - view/add)
Delphinus Appoints Two New Board Members Selections Follow Unprecented Series C Round »
PLYMOUTH TOWNSHIP, Mich. - Delphinus Medical Technologies, Inc. , the leader in advanced breast ultrasound technolog...
Monday, December 21, 2015   (0 Comments - view/add)
Henry Ford Gets New Robotic Technology That Allows Surgery on Tumors Deep Within the Brain »
Henry Ford Hospital   in Detroit is once again redefining the dreaded medical term "inoperable" with an advanced b...
Thursday, December 17, 2015   (0 Comments - view/add)
Armune Inks Deal to Market Prostate Cancer Test as it Positions for $25M Fundraising Round »
KALAMAZOO — An agreement with a Canadian company will significantly expand sales and marketing efforts for   Armune...
Thursday, December 17, 2015   (0 Comments - view/add)
Save The Date: BIO and AdvaMed Legislative Fly-Ins »
2016 dates have now been set for the annual legislative fly-ins hosted by BIO and AdvaMed.   AdvaMed, the nati...
Thursday, December 17, 2015   (0 Comments - view/add)
Tetra Discovery Initiates Phase 1 Study of BPN14770, Under Development for Treatment and Prevention »
Tetra Discovery Initiates Phase 1 Study of BPN14770, Under Development for Treatment and Prevention of Alzheimer’s Disease...
Monday, December 7, 2015   (0 Comments - view/add)
Armune Inks Deal to Market Prostate Cancer Test as it Positions for $25M Fundraising Round »
KALAMAZOO — An agreement with a Canadian company will significantly expand sales and marketing efforts for   Armune...
Wednesday, November 25, 2015   (0 Comments - view/add)
Ash Stevens to Make API For Takeda's New Oral Blood Cancer Drug »
The US FDA has cleared Ash Stevens to make the API for Takeda's new multiple myeloma drug Ninlaro, which is the first oral...
Tuesday, November 24, 2015   (0 Comments - view/add)
SRI International Awarded $100 Million NIAID Contract to Develop Treatments for Radiation Exposure »
MENLO PARK, Calif.—October 13, 2015—SRI International has been awarded a resource contract of up to $100 million over five...
Wednesday, November 18, 2015   (0 Comments - view/add)
Fingerprinting Requirements in Michigan Change for Pharma Companies »
Requirements related to fingerprinting and criminal history checks have changed for applicants seeking a pharmacy, drug ma...
Tuesday, November 17, 2015   (0 Comments - view/add)
Report Out on BARDA Industry Day 2015 »
The following is a summary compiled by G2G Consulting ,  a MichBio Preferred Provider, of key presentations and take...
Thursday, September 10, 2015   (0 Comments - view/add)
Delphinus Raises Over $39 Million in Capital: Largest for Michigan Med Device Company »
Large Series C Round Demonstrates Confidence in Company Leadership, Technology Delphinus Medical Technologies, Inc....
Wednesday, September 9, 2015   (0 Comments - view/add)
Pfizer Closes $15B Hospira Takeover »
From MassDevice Pfizer (NYSE:PFE) yesterday closed its $15 billion acquisition of Hospira, its largest-ever buyout,...
Wednesday, September 9, 2015   (0 Comments - view/add)
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener Epigenetic Methylat »
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claimi...
Wednesday, September 9, 2015   (0 Comments - view/add)
SRI International Licenses DataSpeaks Software for Development of a Virtual Clinical Decision-Making »
SRI International and DataSpeaks, Inc. announced today that SRI has licensed the Science of Individuality Measurement Algo...
Thursday, August 27, 2015   (0 Comments - view/add)
MPI Research, Exemplar Genetics Collaboration First to Validate New Animal Model of Atherosclerosis »
ExeGen® LDLR miniswine offers improved translational value to human clinical trials MPI Research and Exemplar Geneti...
Saturday, August 22, 2015   (0 Comments - view/add)
Novartis Buys Rights to Experimental MS Drug for $1 Billion »
From BloombergBusiness By Simeon Bennett Novartis AG agreed to buy the rights to an experimental multiple scleros...

Displaying page 7 of 10
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal